Tonix Pharma, TNXP, drops 31% on yet another reverse share split - should rise 625% this morning

Tonix Pharmaceutical (NASDAQ: TNXP) shares have not had a good time of it. To all intents and purposes the stock is down 100% - near indistinguishably from that number at least - over the past several years. This of course produces problems for the maintenance of the NASDAQ listing. That's OK, we know how to cure that problem - the reverse share split. The thing is this has been tried before and is being tried, now, again. It didn't work all that well last time - why expect it to do so this?

Which is why on the announcement of this latest reverse split - a 1: 6.25 offering - the stock dropped 31%. Sure, everyone wants the problem solved, but perhaps we've got to the point now where people would like a real solution - like a product that will sell etc - rather than ever more manipulations to the stock count. For on May 16th last year - pretty much exactly a year ago - there was a 1:32 reverse share split to solve that same problem, falling below the NASDAQ minimum bid price. Following which there's been considerable stock issuance and the decline back below $1 which requires doing this all over again. You know, that Einstein thing about doing the same thing over and over yet expecting different results?


 Tonix Pharma stock price from NASDAQ

The likely betting is that this reverse split will be followed by more stock issuance to raise more capital. That's pretty logical, for of course the desire to maintain the NASDAQ listing is so as to be able to raise more capital. But there might perhaps be a limit to how much more capital the market wants to put into the same process that doesn't seem to be working so well. 

More normally a reverse stock split is greeted with a little boost to the real stock price. For it means that more capital can be raised as a result of maintaining the listing. A fall on the announcement could be seen as the market saying “What, again?” which isn't one of those good signs.

5 year Tonix Pharma stock chart

That's not an attractive stock chart there over the 5 year view, is it?